Literature DB >> 23329212

Novel approaches to food allergy.

Yao-Hsu Yang1, Bor-Luen Chiang.   

Abstract

Food allergies have increased in recent decades. However, they cannot be effectively treated by the current management, which is limited to the identification and avoidance of foods that induce allergies and to the use of medicines for symptoms relief. To meet the medical need of prevention and cure of food allergies, several therapeutic strategies are under investigation. Some newly developed biologics such as anti-IgE antibody and anti-interleukin (IL)-5 antibody directed against significant molecules in the allergic process have shown their potential for the treatment of food allergies. Allergen-specific immunotherapy is the therapy that induces immune tolerance and may reduce the need for conventional medication, severity of allergic symptoms and eliminate hypersensitivity. In this article, clinical studies of immunotherapy via subcutaneous, oral, sublingual, and epicutaneous routes are extensively reviewed for their safety and effectiveness on various food allergies. In addition, to reduce the risk of anaphylaxis and increase toleragenic immunity, many studies are focusing on the modification of traditional allergens used for immunotherapy. Moreover, a Chinese herbal formulation with potential anti-allergic effects is being evaluated for its efficacy in patients with peanut allergy. Although more studies are needed, accumulated data of current studies represent compelling evidence of curative effects of some strategies and give a hope that food allergies are likely to be successfully treated in the future.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23329212     DOI: 10.1007/s12016-013-8354-2

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  56 in total

Review 1.  Future therapies for food allergies.

Authors:  Anna Nowak-Węgrzyn; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2011-01-31       Impact factor: 10.793

2.  Specific oral tolerance induction in children with very severe cow's milk-induced reactions.

Authors:  Giorgio Longo; Egidio Barbi; Irene Berti; Rosanna Meneghetti; Angela Pittalis; Luca Ronfani; Alessandro Ventura
Journal:  J Allergy Clin Immunol       Date:  2007-12-26       Impact factor: 10.793

3.  A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy.

Authors:  Hugh A Sampson; Donald Y M Leung; A Wesley Burks; Gideon Lack; Sami L Bahna; Stacie M Jones; Dennis A Wong
Journal:  J Allergy Clin Immunol       Date:  2011-03-11       Impact factor: 10.793

Review 4.  Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses.

Authors:  Michele A Grimbaldeston; Martin Metz; Mang Yu; Mindy Tsai; Stephen J Galli
Journal:  Curr Opin Immunol       Date:  2006-10-02       Impact factor: 7.486

5.  Dietary baked milk accelerates the resolution of cow's milk allergy in children.

Authors:  Jennifer S Kim; Anna Nowak-Węgrzyn; Scott H Sicherer; Sally Noone; Erin L Moshier; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2011-05-23       Impact factor: 10.793

Review 6.  Allergen immunotherapy.

Authors:  Anthony J Frew
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

7.  Time trends in allergic disorders in the UK.

Authors:  R Gupta; A Sheikh; D P Strachan; H R Anderson
Journal:  Thorax       Date:  2006-09-01       Impact factor: 9.139

Review 8.  Epitope peptides and immunotherapy.

Authors:  Soichi Tanabe
Journal:  Curr Protein Pept Sci       Date:  2007-02       Impact factor: 3.272

9.  Effects of omalizumab in patients with food allergy.

Authors:  Asif Rafi; LanAnh T Do; Roger Katz; Lee E Sheinkopf; Caroline Watson Simons; William Klaustermeyer
Journal:  Allergy Asthma Proc       Date:  2010 Jan-Feb       Impact factor: 2.587

10.  Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.

Authors:  Jennifer K Garrett; Sean C Jameson; Blythe Thomson; Margaret H Collins; Lynne E Wagoner; Debbie K Freese; Lisa A Beck; Joshua A Boyce; Alexandra H Filipovich; Joyce M Villanueva; Steven A Sutton; Amal H Assa'ad; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2003-12-12       Impact factor: 10.793

View more
  7 in total

1.  The challenge of treating orphan disease.

Authors:  Carlos Dias; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

Review 2.  The Eosinophil in Health and Disease: from Bench to Bedside and Back.

Authors:  Wei Liao; Hai Long; Christopher Chia-Chi Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

Review 3.  The changing geoepidemiology of food allergies.

Authors:  Patrick S C Leung; Shang-An Shu; Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2014-06       Impact factor: 8.667

Review 4.  Food allergy diagnosis and therapy: where are we now?

Authors:  Aleena Syed; Arunima Kohli; Kari C Nadeau
Journal:  Immunotherapy       Date:  2013-09       Impact factor: 4.196

Review 5.  The Role of Skin Barrier in the Pathogenesis of Food Allergy.

Authors:  Neema Izadi; Minnelly Luu; Peck Y Ong; Jonathan S Tam
Journal:  Children (Basel)       Date:  2015-09-02

6.  Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab.

Authors:  Philippe Bégin; Tina Dominguez; Shruti P Wilson; Liane Bacal; Anjuli Mehrotra; Bethany Kausch; Anthony Trela; Morvarid Tavassoli; Elisabeth Hoyte; Gerri O'Riordan; Alanna Blakemore; Scott Seki; Robert G Hamilton; Kari C Nadeau
Journal:  Allergy Asthma Clin Immunol       Date:  2014-02-20       Impact factor: 3.406

7.  Increasing trends of anaphylaxis-related events: an analysis of anaphylaxis using nationwide data in Taiwan, 2001-2013.

Authors:  Tsung-Chieh Yao; Ann Chen Wu; Ya-Wen Huang; Jiu-Yao Wang; Hui-Ju Tsai
Journal:  World Allergy Organ J       Date:  2018-10-10       Impact factor: 4.084

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.